Digestive and Liver Disease
Volume 43, Issue 1 , Pages 40-47 , January 2011

The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9

  • Jiang Li

      Affiliations

    • Department of Laparoscopic Surgery Unit, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China
    • ,
  • Renhu Sun

      Affiliations

    • Department of Endoscopy Center, the Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, Jiangsu Province, PR China
    • Corresponding Author InformationCorresponding author.
    • ,
  • Kaixiong Tao

      Affiliations

    • Department of Laparoscopic Surgery Unit, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China
    • ,
  • Guobin Wang

      Affiliations

    • Department of Laparoscopic Surgery Unit, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China
    • Corresponding Author InformationCorresponding author at: Department of Laparoscopic Surgery Unit, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Road, Wuhan 430022, PR China. Tel.: +86 27 85726301.

Received 3 December 2009 ,Accepted 20 May 2010.

References 

  1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7–33
  2. August DA, Ottow RT, Sugarbaker PH. Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev. 1984;3:303–324
  3. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2:563–572
  4. Wong CW, Lee A, Shientag L, et al. Apoptosis: an early event in metastatic inefficiency. Cancer Res. 2001;61:333–338
  5. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4:540–550
  6. Zlotnik A. Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol. 2006;13:191–199
  7. Zlotnik A. Chemokines and cancer. Int J Cancer. 2006;119:2026–2029
  8. Schimanski CC, Schwald S, Simiantonaki N, et al. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res. 2005;11:1743–1750
  9. Gunther K, Leier J, Henning G, et al. Prediction of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int J Cancer. 2005;116:726–733
  10. Dieu MC, Vanbervliet B, Vicari A, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med. 1998;188:373–386
  11. Hirao M, Onai N, Hiroishi K, et al. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. Cancer Res. 2000;60:2209–2217
  12. Yu S, Duan J, Zhou Z, et al. A critical role of CCR7 in invasiveness and metastasis of SW620 colon cancer cell in vitro and in vivo. Cancer Biol Ther. 2008;7:1037–1043
  13. Fridman R, Toth M, Chvyrkova I, et al. Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev. 2003;22:153–166
  14. Zeng ZS, Huang Y, Cohen AM, et al. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol. 1996;14:3133–3140
  15. Zucker S, Lysik RM, DiMassimo BI, et al. Plasma assay of gelatinase B: Tissue inhibitor of metalloproteinase complexes in cancer. Cancer. 1995;76:700–708
  16. Lubbe WJ, Zhou ZY, Fu W, et al. Tumor epithelial cell matrix metalloproteinase-9 is a target for antimetastatic therapy in colorectal cancer. Clin Cancer Res. 2006;12:1876–1882
  17. Lubbe WJ, Zuzga DS, Zhou Z, et al. Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9. Cancer Res. 2009;69:3529–3536
  18. Bauvois B, Dumont J, Mathiot C, et al. Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Leukemia. 2002;16:791–798
  19. Redondo-Munoz J, Jose Terol M, Garcia-Marco JA, et al. Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration. Blood. 2008;11:383–386
  20. Hannon GJ. RNA interference. Nature. 2002;418:244–251
  21. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494–498
  22. Sassen S, Miska EA, Caldas C. MicroRNA: implications for cancer. Virchows Arch. 2008;452:1–10
  23. Mori T, Kim J, Yamano T, et al. Epigenetic up-regulation of C–C chemokine receptor 7 and C–X–C chemokine receptor 4 expression in melanoma cells. Cancer Res. 2005;65:1800–1807
  24. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161–174
  25. Saeki H, Moore AM, Brown MJ, et al. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol. 1999;162:2472–2475
  26. Henning G, Ohl L, Junt T, et al. CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720. J Exp Med. 2001;194:1875–1881
  27. Stein JV, Soriano SF, M’Rini C, et al. CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. Blood. 2003;101:38–44
  28. Legrand C, Gilles C, Zahm JM, et al. Airway epithelial cell migration dynamics. MMP-9 role in cell-extracellular matrix remodeling. J Cell Biol. 1999;146:517–529
  29. Weaver AM. Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis. 2006;23:97–105
  30. Mashino K, Sadanaga N, Yamaguchi H, et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 2002;62:2937–2941
  31. Sancho M, Vieira JM, Casalou C, et al. Expression and function of the chemokine receptor CCR7 in thyroid carcinomas. J Endocrinol. 2006;191:229–238
  32. Van Haastert PJ, Devreotes PN. Chemotaxis: signalling the way forward. Nat Rev Mol Cell Biol. 2004;5:626–634
  33. Bogenrieder T, Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene. 2003;22:6524–6536
  34. Sobrero A, Kerr D, Glimelius B, et al. New directions in the treatment of colorectal cancer: a look to the future. Eur J Cancer. 2000;36:559–566
  35. Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352:476–487
  36. Issa A, Le TX, Shoushtari AN, et al. Vascular endothelial growth factor-C and C–C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res. 2009;69:349–357

PII: S1590-8658(10)00195-7

doi: 10.1016/j.dld.2010.05.013

Digestive and Liver Disease
Volume 43, Issue 1 , Pages 40-47 , January 2011

Article Tools

* Image Usage & Resolution